Is Amplify Weight Loss Drug & Treatment ETF a good dividend ETF?

Amplify Weight Loss Drug & Treatment ETF (THNR) is a dividend-paying ETF with a current dividend yield of 1.57%. Review its dividend history, payout consistency and growth to judge whether it fits your income strategy.

What is THNR's dividend yield?

The dividend yield for THNR ETF is currently 1.57%.

How much does THNR pay in dividends per year?

Amplify Weight Loss Drug & Treatment ETF pays an annual dividend of $0.4132 per share over the trailing twelve months.

How often does THNR pay dividends?

THNR ETF pays dividends annually.

THNR Stock Price, Chart, Stats & News

Amplify Weight Loss Drug & Treatment ETF

Save

Overview Dividends Holdings

Amplify Weight Loss Drug & Treatment ETF (THNR) is a dividend-paying ETF with a current dividend yield of 1.57% as of Nov 10, 2026. It pays $0.4132 per share over the trailing twelve months and distributes annually.

Healthcare Equity

THNR chart

THNR returns

YTD	3.01%
1Y	13.06%
1Y volatility	16.98%
3Y volatility	0.00%
Sharpe ratio	0.00

About

The Amplify Weight Loss Drug & Treatment ETF (THNR) offers investors a way to access international firms poised to benefit financially from advancements in weight management pharmaceuticals.

Top 10 THNR holdings

Holding	Ownership
Eli Lilly and Compa… LLY NYSE	Health care 11.78%
Novo Nordisk A/S NVO NYSE	Health care 8.80%
Amgen Inc. AMGN NASDAQ	Health care 6.07%
AstraZeneca PLC AZN NYSE	Health care 5.92%
Regeneron Pharmaceu… REGN NASDAQ	Health care 5.79%
Gilead Sciences, In… GILD NASDAQ	Health care 5.67%
AbbVie Inc. ABBV NYSE	Health care 5.59%
Pfizer Inc. PFE NYSE	Health care 5.28%
Merck & Co., Inc. MRK NYSE	Health care 4.99%
Viking Therapeutics… VKTX NASDAQ	Health care 4.38%